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CLINICAL THERMORADIOTHERAPY 
H.I. Bicher, T.S. Sandhu and F.W. Hetzel 
Henry Ford Hospital 
INTRODUCTION 
The f a i l u r e of conventional radiotherapy to control a s i g n i f i c a n t number of tumors 
without any extensive adverse effects on the surrounding normal tissue i s mainly a t t r i -
buted to the presence of a viable hypoxic f r a c t i o n of c e l l s i n these tumors. As far 
back as 1909 Schwarz showed that r e s t r i c t i o n of blood c i r c u l a t i o n , l i m i t i n g oxygen 
supply, rendered human skin radioresistent. Due to heterogeneous structure of tumors, 
i n general, there are regions containing closely packed c e l l s , remote from blood vessels 
and, therefore, are i n hypoxic state (38). Even a very small f r a c t i o n of hypoxic c e l l s 
can res u l t i n f a i l u r e of radiotherapy to control the tumor. In order to overcome t h i s 
problem of hypoxic c e l l s a number of d i f f e r e n t approaches have been t r i e d . One of the 
early solutions was to give the t o t a l radiation dose i n several fractions. 
During the course of fractionated treatments the resistant hypoxic c e l l s become 
sensitive oxygenated c e l l s . This i s at least true for the l a t e r doses of the m u l t i -
f r a c t i o n treatment schedule. However, i t i s possible that some tumors do not reoxyge-
nate completely such that some hypoxic c e l l s t i l l survive the treatment and are responsi-
ble for the recurrence. Even a modest number of hypoxic c e l l s would constitute a serious 
problem. A si g n i f i c a n t e f f o r t has been made to compensate for t h i s l i m i t a t i o n . One 
solution i s to use high linear transfer (LET) radiation instead of ordinary x- and 
Y-rays, such that the tumor response i s independent of the presence or absence of mole-
cular oxygen. The ideal radiation which w i l l have oxygen enhancement (OER) of unity, 
such as 2MeV a- part i c l e s i s incapable of penetrating s u f f i c i e n t tissue thickness to be 
of any use. The best that can be achieved i s to use neutrons, pions or high-energy 
heavy ions. These options tend to be very expensive and limited c l i n i c a l t r i a l s are 
s t i l l on going. 
Another approach has been to place the patient i n an environment of pure oxygen at 
a pressure of 2 to 3 atmospheres prior to radiotherapy i n an attempt to increase the 
a v a i l a b i l i t y of oxygen to tumors. This technique has f a i l e d to produce any s i g n i f i c a n t 
improvement i n tumor control although a few centers around the world are s t i l l conducting 
c l i n i c a l t r i a l s . 
In recent years there has been an increasing interest i n use of hyperthermia, either 
used alone or i n combination with radiation i n the treatment of cancer. Although reports 
on the use of hyperthermia date as far back as 1866 (5), the research i n the use of hyper-
thermia as a possible, c l i n i c a l l y important, anti-tumor treatment modality either used 
alone or i n combination with radiation therapy has been stimulated i n the past two de-
cades as a result of several interesting findings i n thermoradiobiological studies. The 
rationale for using hyperthermia i s discussed next. 
B. Rationale 
Recent extensive radiobiological and lim i t e d c l i n i c a l studies show that hyperthermia 
combined with radiation has a synergistic c e l l k i l l i n g e f f e c t . Both i n - v i t r o (21,31,32, 
40) and in-vivo (12,13,15,29,39) studies show that the thermal enhancement depends not 
only on the sequence of the two treatments, but also on c e l l cycle effects. The syner-
g i s t i c effect iff most pronounced for radioresistent S-phase c e l l s (10,38). From a 
c l i n i c a l point of view the most important observation i s that the hypoxic c e l l s may be 
equally or more sensitive to hyperthermia than aerobic c e l l s (9,21,29,35). The rationale 
for using hyperthermia above 430C i n combination with ionizing radiation i s that the 
viable hypoxic tumor c e l l s , which are radioresistant, w i l l be destroyed by hyperthermia 
at these temperatures. Another interesting aspect i s that mild hyperthermia (40 to 42°) 
introduces a s i g n i f i c a n t change i n tumor blood flow. I t has been shown both i n mouse 
tumor and c l i n i c a l l y (4) that hyperthermia i n 40 - 42°C range increases the blood flow 
with a concomitant increase i n oxygenation. This w i l l e f f e c t i v e l y sensitize the other-
wise radioresistant hypoxic c e l l s i n the tumor. Dramatic changes i n c e l l survival during 
hyperthermia also have been observed when pH of c e l l s i s only s l i g h t l y altered (11). 
Although there i s no i n - v i t r o data indicating d i f f e r e n t i a l response or sensitization of 
tumor c e l l s as opposed to normal tissue c e l l s , the c e l l u l a r environment i n the two cases 
is expected to be quite d i f f e r e n t in-vivo. For example, several studies (8,16,27,28) i n -
dicate that pH of f l u i d i n human and rodent solid tumors i s lower than the normal pH of 
7.4. This w i l l r e s u l t i n d i f f e r e n t i a l tumor c e l l k i l l i n g with normal tissue sparing. 
Other studies (2,24) indicate that some tumors have sluggish blood flow as compared to 
normal tissue. This suggests that under similar heating conditions, tumors are not able 
to dissipate heat as e f f i c i e n t l y as the normal tissue re s u l t i n g i n d i f f e r e n t i a l tumor heat-
ing^ These findings about the d i f f e r e n t microenvironments i n tumors and normal tissue re-
garding pH, blood flow and n u t r i t i o n a l state probably led the ea r l i e r investigators (6,14,-
23,34), to conclude that tumor c e l l s are selectively k i l l e d by hyperthermia. 
Based on above i n - v i t r o and in-vivo radiobiological findings several groups of i n -
vestigators (2,4,19,20,23,26) are engaged i n c l i n i c a l studies employing a combination of 
hyperthermia and ionizing radiation. The c l i n i c a l goals, methodology and results of some 
of these studies are discussed i n the following section. 
C. C l i n i c a l Thermoradiotherapy. 
C l i n i c a l applications of combined hyperthermia and radiation treatment modality date 
back to the ea r l i e r part of the century. The early reports are anecdotal i n nature. Most 
of them reported only an attempt to treat human tumors. The temperatures to which tumors 
and surrounding normal tissues were heated were not documented. This along with lack of 
radiation alone controls make i t very d i f f i c u l t to draw any quantitative conclusions. In 
some cases i t i s d i f f i c u l t to establish that tumor temperature was raised at a l l since no 
temperature measurements were made. 
The e a r l i e s t report of combining hyperthermia and ionizing radiation i s that of 
Schmidt (33). He proposed the use of diathermy for localized heating of tissue to treat 
malignacies i n combination with ionizing radiation. Arons and Sokoloff (3) used radiofre-
qqency (RF) currents for hyperthermic treatments of intrathoracic and intra-abdominal tumors. 
I t is d i f f i c u l t to establish whether they were able to raise the tissue temperature to 
therapeutic range since no temperature measurements were made. Woeber (42) used ultrasound 
with simultaneous x - i r r a d i a t i o n to treat 20 patients with cutaneous malignancies. He reported 
a 40% reduction i n radiation dose required for tumor control accompanied by a reduction i n 
normal tissue reaction. Crockett et a l . (7), following some experimental work on normal dog 
bladder treated 7 elderly patients with incurable advanced bladder carcinomas with a combina-
t i o n of local hyperthermia and regional radiotherapy. The radiation dose varied from 4500 
to 5500 rads. These authors reported s t r i k i n g reduction i n tumor size with no serious ad-
verse effects. The authors suggested that the tumor response was enhanced by hyperthermia. 
The authors, however, did not make any attempt to determine heat d i s t r i b u t i o n w i t h i n the 
bladder. Recently Hall (17) also reported regression of bladder papillomatosis without 
any complications. He heated the bladder by i r r i g a t i o n with water heated to 42 - 45°C. 
The patients were heated for 3 hours for 5 to 14 sessions. 
Hartman and C r i l e (18) reported treatment of osteogenic sarcoma with microwave 
heating and various doses of radiation. Five children were treated with t h i s combination. 
Two of f i v e , one 7 year old g i r l with osteogenic sarcoma i n the r i g h t mid-tibia, and a 16 
year old boy with an os t i o b l a s t i c and osteolytic lesion of the metaphysis of the d i s t a l 
part of the l e f t radius, were a l i v e f i v e years l a t e r . The other three survived 6 to 17 
months and died of metastatic disease. The two patients who had long term survival also 
retained function of the limb. 
Stehlin (37) reported a 67% five-year survival for 32 patients he treated using 
heated blood for perfusion of the extremities. These hyperthermia treatments were f o l -
lowed by x - i r r a d i a t i o n several weeks l a t e r . I t was found that tissue temperatures of 
40°C using his technique were tolerated very well for several hours. However, perfusion of 
extremities with blood heated to 46°C resulted i n complications. 
In the past few years several prospective c l i n i c a l t r i a l s have been stated. The 
results of the Henry Ford Hospital t r i a l are reported here. 
Materials and Methods 
In t h i s study a f r a c t i o n a t i o n scheme combining hyperthermia and radiation was de-
signed with a curative i n t e n t . The protocol i s summarized i n Table I . 
This protocol has been designed to take advantage of known effects of hyperthermia 
either alone or i n combination with radiation. Skin cooling was implemented to prevent 
normal tissue damage. The number of fractions and duration of each treatment was a r b i -
t r a r i l y chosen, taking into account factors such as patient compliance, patient comfort 
and possible b i o l o g i c a l factors such as thermotolerance, vascular response and repair. 
In addition, the t o t a l dose of radiation employed i s s u f f i c i e n t l y low to allow r e t r e a t -
ment of previously irradiated areas. 
Localized hyperthermia was induced i n a l l patients by microwave radiation employing 
direc t contact applicators (30). The tumor size, location and depth determine the exact 
applicator type and size as well as the microwave frequency (915 or 300 MHz) that are 
employed.* Heat i s i n i t i a l l y applied to the tumor i n four fractions of l h hour duration 
at intervals of 72 hours. The temperature i s monitored with either conventional (Bailey) 
or ultramicro thermocouples (Medtra Inc.) to maintain the tumor temperature at 45°C ± 
0.5°C while the overlying, normal skin i s simultaneously maintained with a i r cooling at 
or below 360C. Following these 4 fractions the patient rests for one week. Fi n a l l y , four 
more fractions of hyperthermia are given; t h i s time i n combination with radiation. Each 
of these 4 treatments consists of dose of 400 rad to the tumor iinmediately followed 
(<20 min.) by hyperthermia to a temperature of 42.0 + 0.5°C. 
These fractions are again separated by 72 hours; as before, skin cooling i s used 
when necessary to maintain a temperature of 36°C or lower at the surface. The microwave 
hyperthermia was induced using dire c t contact applicators. These applicators are essenti-
a l l y square or rectangular cross-section waveguides. Two types of microwave applicators 
were employed i n t h i s study. One type i s square or rectangular cross-section waveguide 
completely }.oaded with a low-loss d i e l e c t r i c material and excited i n TE^Q mode (30) . The 
other type of applicator employed i s p a r t i a l l y f i l l e d rectangular waveguide excited i n the 
* A l l equipment by Medtra Inc., Detroit 
TABLE I 
Proposed "curative" fractionation; 
Hyperthermia + Radiation Therapy 
1. Hyperthermia only - 4 Treatments 
45°C - 90 Minutes, (skin 36°C or below) 
treat every 72 hours. 
2. Rest 1 Week 
evaluate response to heat alone. 
3. Radiation Therapy and Hyperthermia - 4 treatments 
42°C - 90 minutes 
Heat follows radiation (20 minute i n t e r v a l ) 
RT: 400 rad fractions - Each treatment 
Total - 8 Hyperthermia treatments 
+ 1600 rads/2 weeks/4 fractions 
TEM mode. This pa r t i c u l a r design results i n a better heating d i s t r i b u t i o n as compared 
to that of TEio mode applicator.* Thermometry was accomplished using ultramicrothermo-
couples,* one or two of these inserted i n the tumor tissue depending upon the size and 
location. 
Results 
At t h i s time 62 patients have been treated with a t o t a l of 82 f i e l d s . Tables I I 
and I I I summarize the results. A t o t a l response i s observed i n 49 treatment f i e l d s 
and a p a r t i a l response in 27. No response was observed i n only 6 f i e l d s . These i n -
cluded 1 squamous c e l l carcinoma, 1 adenocarcinoma and 1 sarcoma. The only com-
plications that were d i r e c t l y a t t r i b u t a b l e to treatment were 2 skin burns as a result 
of inadequate surface cooling and 2 tongue and pharynx burns. A l l of these healed com-
plet e l y . One patient with a history of epilepsy experienced a grand mal siezure during 
treatment of a neck tumor. Three marginal recurrences and 5 local recurrences have been 
noted. Although i t should be emphasized that great care i s needed during the i n i t i a l 
planning and set-up for the patient, i t i s feasible to obtain actual thermometry for 
every treatment of every f i e l d with minimum patient discomfort. 
Table I I I summarizes results by histology. I t indicates that malignant IjTnphoma 
is most responsive to t h i s combination treatment. I t should be pointed out that tumor 
regression following completion of treatment i s very slow and requires approximately 
two months before the t o t a l effect i s observed. Another interesting observation made 
during these treatments i s that the microwave power required to maintain the desired 
treatment temperatures declines following the f i r s t or second treatment of a given f i e l d . 
These two phenomena are probably related to heat induced physiological changes wi t h i n 
the tumor which are involved i n the ultimate destruction of the tumor. Further physio-
l o g i c a l studies are currently i n progress. 
Another interesting outcome of t h i s study i s to speculate on the possible meaning 
of the three marginal recurrences; they may indicate that t h i s combined modality i s 
effec t i v e i n the treatment of microscopic disease. More time for follow-up and the i n -
put of more patients i s required before a true evaluation of the c l i n i c a l efficacy of 
thi s protocol can be made. 
Discussion 
Recent studies (2,4,19,20,23,25,41) involving a combination of hyperthermia and 
x- i r r a d i a t i o n have made a serious e f f o r t to measure and document the hyperthermia t r e a t -
ments more accurately. In most cases a comparison with radiation alone controls is made. 
Kim et a l . (23) have treated 50 patients with a variety of cutaneous tumors. Improved 
results are reported for both the radiosensitive ( i . e . mycosis fungoides) and radioresis-
tant ( i . e . melanoma) tumors with the combined hyperthermia and radiation treatment as com-
pared to either of these modalities used alone. These authors report complete disappear-
ance of multiple recurrent melanoma nodules without unusual normal skin reactions. How-
ever, combination therapy did produce enhanced skin reactions i n patients whose treated 
areas included either a skin g r a f t or heavily scarred skin from extensive surgery. 
In t h e i r study the above authors report 78% overall tumor control rate a f t e r com-
bined therapy as compared with 26% afte r radiation alone. These investigators u t i l i z e d 
two heating methods. Some patients with tumors on extremities were heating by immersion 
in waterbath. The rest of the patients were treated using RF (27.12 MHz) inductive heating. 
* A l l equipment by Medtra Inc., Detroit 
TABLE I I 
82 Fields treated: 
Total Response 










Skin burns: 2(completely healed) 
Tongue and pharynx 
burns: 2(completely healed) 
Grand seizure: l(neck treatment) 
(e p i l e p t i c patient) 




Squamous c e l l carcinoma 
Ad eno carc inoma 
NO. OF FIELDS 
Other ( t r a n s i t i o n a l c e l l , 







6 P a r t i a l 
3 No Response 
8 Total 
7 Total 
11 P a r t i a l 
1 No Response 
24 Total 
8 P a r t i a l 
1 No Response 
2 Total 
3 P a r t i a l 
FOLLOW-UP (Months) 
2 months - 1 year 
2 - 7 months 
2 - 6 months 
2 - 7 months 
2 - 9 months 
Summary 82 49 Total 
27 P a r t i a l 
6 No Response 
2 months - 1 year 
Total Response: 
Pa r t i a l Response: 
No tumor at 2 months follow-up and thereafter. 
Tumor decreased i n size to half or less at 2-months follow-up. 
I t should be pointed out that there i s a great deal of v a r i a t i o n i n both the radiation 
dose and the hyperthermia treatment duration as well as i n the number of fractions. 
The radiation doses employed varied from 800 rad i n two fractions for melanoma to 2400 
rad i n 8 fractions for Karposi sarcoma. Similarly hyperthermia (43.5°C) treatments vary 
from 2 fractions of 30 min. for melanoma to 5 fractions of 60 min. for mycosis fungoides. 
The hyperthermia treatments followed iinmediately the radiation treatments i n a l l cases. 
This data does not suggest any particular treatment schedule for a particular tumor. 
The study does, however, demonstrate the improved effectiveness of combined thermoradio-
therapy as compared hyperthermia or radiation alone. 
Hornback et a l . (19) treated 72 patients with advanced cancer using the combined 
therapy. Of the patients treated with hyperthermia prior to radiation therapy, 53% ex-
perienced complete remission of symptoms while i n the group of patients treated with 
heat following radiotherapy, 92% showed complete remission. Again there was no set pro-
tocol and the radiation doses varied from 50 to 600 rad per day with t o t a l doses from 
3000 to 6500 rads. Heat treatments were given using 433.92 MHz microwaves. Although the 
authors mention having attempted to measure tumor temperature during these treatments, 
there i s no mention of tumor temperatures achieved i n the patients. 
Johnson et a l (20) conducted a p i l o t study to evaluate normal skin and melanoma 
tumor thermal enhancement rat i o s of 41.5 to 42°C hyperthermia with radiation. The 
response of normal skin to the treatment was measured by evaluating the degree of 
erythema according to a numerical scoring system. Tumor response was assessed by 
measuring tumor diameter. Although the study was not conclusive about the thermal en-
hancement r a t i o , i t did bring to l i g h t some of the problems associated with obtaining 
useful c l i n i c a l data. The study involved patients with multiple metastatic melanoma 
lesions. At least three lesions were chosen on each patient. The patients were divided 
into three groups and given one, 3 or 4 fractions, with a minimum 72 hours i n t e r v a l be-
tween each f r a c t i o n . Radiation dose per f r a c t i o n for d i f f e r e n t lesions on a patient 
varied from 500 to 900 rad. In some cases single fractions of 1000, 1100, 1200 or 1300 
rad were used. On a l l patients one lesion was heated immediately following radiation 
therapy and the other two or more lesions treated with radiation alone were used for com-
parison. Hyperthermia treatments were administered using 915 MHz dir e c t contact micro-
wave applicators (30). Duration of hyperthermia treatments varied between 1 and 2 hours 
at 41.5-42.0OC. 
Skin enhancement r a t i o (SER) and tumor enhancement r a t i o (TER) could be evaluated 
only for a limited number of patients because of lack of follow up data. SER values 
varied from 1.2 to 1.7 while TER values i n most cases were 1.3. This ^tudy demonstrated, 
however, that s u p e r f i c i a l tumors up to 4cm i n diameter and 2cm depth could be heated 
with an accuracy of ± 0.5°C either during, or af t e r radiation with 915 MHz microwaves. 
Manning et a l . (26) reported a very l i m i t e d study combining heat and radiation. Of 
the 40 patients treated with hyperthermia, four were treated i n combination with radiation. 
Each had a minimum of 3 nodules. One nodule received a heat treatment of 43°C for 40 
minutes using radiofrequency currents. Another nodule received radiation alone from two 
radium needles to a dose of 4000 rads i n 100 hrs. A t h i r d lesion had the same dose plus 
simultaneous heat to 43°C for 40 minutes using radium needles as heating electrodes. 
The response rate for heat-radiation combination was 80-90% compared with 50% res-
ponse rate for heat alone and radiation alone groups. The authors suggest a beneficial 
therapeutic r a t i o and minimal side effects from the combined treatment. 
Another limited study (41) treated two groups of patients with radiotherapy alone, 
hyperthermia alone, and combined treatment. One group of patients received 200-600 rad 
fractions, 2-5 times per week to a t o t a l of 1800-4200 rad i n 5-14 fractions. The other 
group of patients received the combined thermoradiotherapy treatments only, radiation 
fractions of 200-600 rad, 2-5 times a week to a t o t a l of 2000-4800 rad i n 6-20 frac-
tions. Hyperthermic treatments for both groups was 42-44^0, 2-3 times per week to a 
maximum of ten sessions i n four weeks. Hyperthermia treatments were given using either 
2450 or 915 MHz microwaves. The f i r s t group of 8 patients, six patients experienced 
complete regression of lesions treated with radiation plus hyperthermia w i t h i n one 
month of therapy. None of the tumors treated with hyperthermia alone regressed com-
plet e l y . In the second group of patients 73% showed tumor regression. Melanoma re-
gressed completely i n 2/4 cases. No adverse side effects were observed on normal 
tissue from the combined treatments. 
Another interesting study was reported by Arcangeli et a l . (2). Fifteen patients 
with multiple neck node metastases from head and neck were treated with either radiation 
alone or i n combination with hyperthermia. A t o t a l of 33 neck nodes were treated, 12 
with radiation alone and the rest with the combination. Hyperthermia was induced by 
500 MHz microwaves using a non contact applicator. These investigators used a very 
interesting f r a c t i o n a l scheme. Described as a multiple d a i l y f r a c t i o n a l (MDF) scheme, 
i t consists of 200 + 150 + 150 rad/day, 4-5 hour i n t e r v a l between fractions, 5 days per 
week, up to a t o t a l of 4000/7000 rad. A l l the lesions were irradiated with the same 
t o t a l dose, whether or not they received hyperthermia. 
The MDF schedule resulted i n 46% complete response which was enhanced to 85% com-
plete response when combined with hyperthermia, the remaining 15% showed p a r t i a l 
response. I t should be noted that i n the treatment schedule, when MDF was combined with 
hyperthermia, heat was applied immediately a f t e r the second daily f r a c t i o n . The authors 
did not observe any abnormal reactions i n areas that were treated with combined t r e a t -
ment . 
In the study reported here, an overall t o t a l response rate of 60% has been obtained. 
Although further study and follow-up are necessary and other protocols must be examined, 
i t i s clear from these results that regardless of anatomical location and tumor histology, 
hyperthermia appears to be an e f f e c t i v e modality i n the treatment of malignant disease. 
Abstract 
A c l i n i c a l t r i a l i s currently i n progress to determine the efficiency of 
combined fractions of hyperthermia and radiation. The protocol consists 
of two parts. F i r s t , 4 fractions of microwave induced hyperthermia 
(45.0 ± O.50C) are applied for l - h hours to the volume encompassing the 
tumor, each separated by 72 hours. Allowing for a one week rest, a second 
series of four fractions are administered again at 72 hour in t e r v a l s . 
Each of these fractions consists of a 400 rad dose of radiation followed 
withi n 20 minutes by hyperthermia (42.5 ± O.50C) for l - h hours. 
Currently 82 f i e l d s have been treated on 62 patients with a mean follow-up 
time to date of 6 months. Total regression i s seen i n 60% of a l l cases, 
p a r t i a l regression i n 33% and no response i s seen i n only 6% of a l l t r e a t -
ments; 5 loc a l and 3 marginal recurrences have been observed. Details of 
response based on s i t e , histology and c l a s s i f i c a t i o n are discussed. 
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